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Fatigue and the Search for 
Its Cause 
It is human nature to seek to understand and
remedy suffering. People process information
from their environments and interactions
through filters determined by their internal
belief systems, thought processes, and experi-
ences. The models thus produced, further
shaped and molded by societal norms, are
then used to interpret experiences (symp-
toms). Once people have a working model,
they seek to understand the origins of their
symptoms and to develop a plan of action
intended to diminish or eliminate their
suffering and anxiety.
In our society, fatigue, pain, weakness,
and malaise are common complaints, often in
people with no objective ﬁndings on physical
examination or laboratory testing. Especially
relevant to people with vague complaints is
the fact that “objective diagnostic testing” is
usually not “diagnostic.” Most serological
tests have high rates of false positivity and a
false positive result can be incorrectly inter-
preted as “proof” of diagnosis. This is all too
common in rheumatology, where a weakly
positive antinuclear antibody test is often
interpreted as proof of systemic lupus erythe-
matosus and a weakly positive rheumatoid
factor as proof of rheumatoid arthritis.
Evaluation by a competent rheumatologist is
often sufﬁcient to determine that the test and
diagnosis are incorrect. No ulterior motive is
ascribed to the disabusing clinician. The test
and the diagnosis are accepted as having been
false alarms and the patient is reassured that
she or he does not have one of these serious
chronic illnesses. Patients who continue to
suffer but are offered no diagnosis to ﬁll the
void left by the reversal of the incorrect diag-
nosis remain concerned, even frightened, but
not necessarily angry.
Suffering, by its very nature visceral and
preverbal, is amorphous. Specific manifesta-
tions and explanations of the suffering are
often profoundly influenced by socially
acceptable constructs. As pointed out by
Shorter (1), there have been many examples
of fatigue and other subjective complaints
being formulated into a “speciﬁc” diagnosis,
even without objective ﬁndings on examina-
tion or specific abnormalities in the labora-
tory. The “energy” of feeling as if one does
not “fit” into societal expectations probably
exists in all societies. The different manifesta-
tions (“packaging,” if you will) are deﬁned by
societal social norms and mores. The energy,
like a vapor, expands to entirely ﬁll and take
on the shape and dimensions of the container
offered. So it was for “myalgic encephalitis,”
“atypical poliomyelitis,” “chronic brucellosis,”
“the Candida connection/chronic candidia-
sis,” and “chronic Epstein-Barr virus infec-
tion.” Once these were debunked and
discarded, one could conﬁdently predict that
another popular container would emerge.
Lyme Disease: The Rush 
to Diagnosis
In 1975, an epidemic of “juvenile rheumatoid
arthritis” was identified in three small com-
munities on the east bank of the Connecticut
River (2). Through a series of epidemiologic
studies,  investigators determined that this
outbreak was actually an inflammatory syn-
drome due to a tick-borne infection [spread
by Ixodes scapularis, the deer tick, in the
Northeast and Midwest and I. paciﬁcus in the
Pacific states (3)]. Ultimately the causative
organism, Borrelia burgdorferi (3), was identi-
fied, serologic tests were developed, and the
natural history of this zoonotic infection, in
human and animal hosts, was understood.
We now know that Lyme disease is the most
common tick-borne infection in the United
States (3), prevalent where there are ixodid
ticks, as described above. The endemic area
has been steadily growing, probably because
the ticks that spread the infection are carried
by the expanding (both numerically and geo-
graphically) deer population and by passerine
birds during their migrations (3). In the
Northeast there has been a remarkable change
in ecology. Forest lands that were clear-cut
and burned to make way for farms in the
17th and 18th centuries were abandoned
with the westward migration of the 19th cen-
tury and allowed to return to forest (4). At
the end of the 20th century, suburban
encroachment placed refugees from urban
centers on land that now represented eco-
niches optimal for deer and mouse popula-
tion explosions. With increases in these
mammal populations comes a remarkable
increase in the tick population. Thus, Lyme
disease has become a public health problem
because the development of more “environ-
ment at risk” has occurred at the very time
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Unexplained Symptoms
Lyme disease is a relatively well-described infectious disease with multisystem manifestations.
Because of confusion over conﬂicting reports, anxiety related to vulnerability to disease, and sensa-
tionalized and inaccurate lay media coverage, a new syndrome, “chronic Lyme disease,” has
become established. Chronic Lyme disease is the most recent in a continuing series of “medically
unexplained symptoms” syndromes. These syndromes, such as ﬁbromyalgia, chronic fatigue syn-
drome, and multiple chemical sensitivity, meet the need for a societally and morally acceptable
explanation for ill-deﬁned symptoms in the absence of objective physical and laboratory ﬁndings.
We describe factors involved in the psychopathogenesis of chronic Lyme disease and focus on the
confusion and insecurity these patients feel, which gives rise to an inability to adequately formu-
late and articulate their health concerns and to deal adequately with their medical needs, a state of
disorganization termed aporia. Key words: aporology, chronic Lyme disease, Lyme disease,
medically unexplained symptoms, misdiagnosis, psychological, psychopathogenesis.
Environ Health Perspect 110(suppl 4):607–611 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-4/607-611sigal/abstract.html608 VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 • Environmental Health Perspectives
that large numbers of people are moving into
these very areas. Lyme disease, either local or
acquired on a visit to an endemic area, has
become a reasonable consideration in many
regions of the United States where it might
not have been included in the appropriate
differential diagnosis even a few years ago.
With a fuller appreciation of how
B. burgdorferi and I. scapularis survive have
come a number of efforts to control the dis-
ease, for example, deer population control,
tick control by spraying properties, killing
ticks on deer by use of deer feeding stations
equipped with acaricide treatment stations,
and deer exclosure fencing. Individuals have
taken personal responsibility by clearing forest
clutter and shrubbery to decrease the peri-
domestic habitat conducive to tick population
growth, doing tick checks at the end of days
spent in high-risk areas, and using vaccine (5).
Nonetheless, there has certainly been no
remarkable decrease in the number of cases
reported to the Centers for Disease Control
and Prevention; these statistics are widely (and
correctly) held to be an underestimate of the
true number of cases. Adding to the difﬁculty
in interpreting these statistics is the fact that
they represent the county of report, not the
county of acquisition of the disease.
The clinical spectrum of B. burgdorferi
infection is now well known (3) and
includes dermatologic, musculoskeletal, neu-
rologic, and cardiac features occurring dur-
ing three somewhat arbitrarily described
different “stages”: early localized disease,
early disseminated disease, and late disease.
Early localized disease includes the classic ery-
thema migrans rash occurring at the site of
the tick bite. Many patients experience satel-
lite lesions, due to hematogenous spread,
and nonspecific symptoms similar to those
of a “viral syndrome,” including arthralgias,
myalgias, headache, and low-grade fever.
Early disseminated disease includes neurologic
damage (meningitis, cranial nerve palsy—
most frequently facial nerve palsy—and
peripheral neuropathies) and cardiac disease
(usually conduction defect, which may be
symptomatic). Ophthalmologic disease is
uncommon. Late disease can include arthri-
tis, at first migratory and then usually
mono- or oligoarticular, and neurologic
findings different from those of earlier dis-
ease, now including cognitive dysfunction
and subtle polyradiculoneuropathies. The
latter two “stages” may occur without
antecedent erythema migrans or illness sug-
gesting the onset of B. burgdorferi infection.
There are other clinical problems ascribed to
Lyme disease, often by dint of only serologic
tests of dubious value—these linkages are
often tenuous. Some features of early Lyme
disease (e.g., high fever, liver function test
abnormalities, cytopenias) are actually due
to other tick-borne pathogens co-infected
with B. burgdorferi.
There is often a rush to make the diagno-
sis of Lyme disease predicated on ﬂimsy evi-
dence, frequently based on a test rather than
on clinical evidence (6,7). Serological testing
can help conﬁrm the diagnosis of Lyme dis-
ease and, when used appropriately, can be
quite helpful. However, these are not Lyme
disease tests; they are merely tests that mea-
sure antibodies that bind to B. burgdorferi in
an in vitro assay. These tests should never be
used as screening tools; a positive test cannot
inform a diagnosis in isolation. Nonetheless,
weakly positive tests without immunoblot
verification [crucial because the screening
enzyme-linked immunoadsorbent assay
(ELISA) is prone to false-positives] are often
the sole evidence in favor of the diagnosis. 
Contrary to the examples noted above,
denial of the diagnosis of Lyme disease often
evinces anger and indignation from the
patient. The frustration of having the
chosen/accepted explanation for their suffer-
ing removed is almost intolerable (6–8).
Having Lyme disease holds a certain appeal
for patients searching for answers for a num-
ber of reasons. Like multiple chemical sensi-
tivity syndrome, there is an identifiable
environmental cause to which the patient
fell victim. They are not to blame for their
illness. The illness was obtained during
healthy and societally acceptable activities
such as gardening, hiking, and picnicking.
Furthermore, Lyme disease has become a
part of our culture. Media exposure has
made Lyme disease, a relatively uncommon
ailment, seem to be common to the public.
Lyme disease is real, a curable illness with a
well-established treatment, unlike the other
medically unexplained symptoms (MUS),
conditions such as fibromyalgia and chronic
fatigue syndrome. Finally, Lyme disease is
not fibromyalgia or chronic fatigue syn-
drome, which some medical practitioners
have come to view with an unjustified
disdain (9) as being “all in your head.”
Early in the process of clinical description,
an unfortunate term was used in reference to
Lyme disease: “the great imitator” (10). This
term was originally used to describe syphilis,
at its height a great mimic of other diseases.
Mimicry by Lyme disease was raised as an
issue in the days shortly after its description in
order to raise the awareness of physicians in
endemic areas. Unfortunately, the term took
on a life of its own, and some advocacy groups
and physicians accepted a premise that
B. burgdorferi infection could perpetrate
nearly any clinical deed (6,7). The claims
mounted: B. burgdorferi could cause an illness
that defied routine serologic tests, did not
include antecedent or current features of
Lyme disease, and was unrecognizable by the
very scientists who first described Lyme
disease. B. burgdorferi could cause an illness
that persisted despite aggressive antibiotic
therapy. B. burgdorferi could cause a progres-
sive illness with features including fatigue,
malaise, pain and cognitive dysfunction but
no objective signs of tissue damage (6,8).
Lyme Disease: The Latest
“Cause” of Fatigue
By the end of the 20th and start of the 21st
century, Lyme disease has become a major
public health issue in certain American com-
munities, and unfortunately battle lines are
being drawn. On the basis of scientiﬁc study,
the physician-scientists and their supporters
(the “rationalists”) are concerned about a
tick-borne illness that can be diagnosed and
treated, has a good prognosis, and can be pre-
vented. However, there is also a “countercul-
ture” of myth and speculation describing
another “Lyme disease,” an “alternative real-
ity” claiming that there is “chronic Lyme dis-
ease,” an incurable, irreversible, irretrievable
illness, based on unproven premises. These
“empiricists” are concerned about chronic
Lyme disease, a clinical entity based on med-
ical models often at odds with the scientifi-
cally corroborated features—clinical,
microbiologic, and immunologic—of Lyme
disease. Chronic Lyme disease has been used
as the diagnosis to explain a variety of com-
plaints. It is our premise that chronic Lyme
disease is yet another in a long series of “con-
tainers” for ill-deﬁned suffering (the energy or
“vapor” alluded to above), giving it form and
illusory “substance.” That these people are
not well is not the proper focus of inquiry or
debate—they are manifestly ill. The root
cause and underlying mechanism of their
illness should be the focus.
Some of these patients have, in fact, been
diagnosed as having Lyme disease. Then why
do they not improve with antibiotic therapy?
A series of explanations for persistence of
complaints despite antibiotic therapy that
would be considered adequate was proposed
in 1994 (11). Such explanations included
a) symptoms unrelated to Lyme disease—
initial misdiagnosis; b) Slowly resolving Lyme
disease; c) permanent tissue damage, not
responsive to antibiotics; d) factors related to
chronic illness; e) sterile infection caused by
dead organism; f ) post-Lyme disease syn-
dromes, possible reactive phenomena; and
g) true persisting infection with B. burgdorferi.
Initial misdiagnosis by others is
commonly the reason for patients not
improving in our practice; the rush to make
this diagnosis often leaves logic and reason far
behind. Many patients improve slowly after
antibiotics, up to 50% having persisting non-
specific complaints that last 6 months or
more. When the correct diagnosis of Lyme
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disease is delayed (or, rarely, when the course
of the disease is aggressive), damage may have
occurred that cannot resolve even when the
infection is eradicated. This has been the case
in a few patients with permanent heart block
or facial palsies that have not totally resolved.
We have seen many patients with complaints
referable to poor sleep, poor physical condi-
tioning, anxiety, depression, or muscle atro-
phy. In these cases, no active infection was
identified, often the initial diagnosis was in
error, and nonantibiotic therapy was war-
ranted. Inﬂammation and organ dysfunction
may persist even after B. burgdorferi is killed
by host defenses and antibiotics, with residual
debris acting as a persisting focus of inflam-
mation (12). Until the organism is cleared
from the site of infection, there may be active
“disease” without active infection. “Post-
Lyme disease syndrome” has been the subject
of much debate, but no immunopathogenic
process has been identified (12). There has
been speculation that immunologic cross-
reactivity between the organism and a host
component may drive inﬂammation, but this
has not been proven (12). Many patients with
post-Lyme disease syndrome actually have
fibromyalgia, a phenomenon first identified
by our group (13,14) and corroborated by
others (15). Finally, there is the theoretical
possibility that the organism may survive
antibiotics and cause ongoing inﬂammation.
This is unproven and implausible in the set-
ting of ongoing seronegativity and the
absence of any physical ﬁndings of inﬂamma-
tion or objective tissue damage.
Any of these may be the true explana-
tion for the patient’s ongoing suffering, but
none save the last represents ongoing infec-
tion, nor will they respond to further
antibiotic therapy. Many sufferers have
taken antibiotics for many months and
years, obtaining no lasting relief. Oral and
intravenous antibiotics, in combinations or
sequential cycles, even self-induced malaria
(for a pyrexia-induced cure as was used
many years ago for neurosyphilis) have been
tried. A recent trial of long-term antibiotics
funded by the National Institutes of Health
was closed because it failed to show any
effect on the ongoing complaints of patients
with chronic Lyme disease (16). And yet
these patients cleave to the diagnosis of
chronic Lyme disease, often demanding
more antibiotics that do not offer a surcease
to their suffering. There is reason to seek
alternative explanations for these refractory
cases. The antibiotics used have toxicities
often worse than the patient’s original prob-
lems—avoidance of further iatrogenic dam-
age is important (8,17). If the diagnosis of
Lyme disease is in error, another process is
not being dealt with. Correct treatment is
not being given for the real illness. If anti-
biotics have not worked, there is scant hope
for the future. There is need to give the
patient a cause for optimism.
Although providing care for these
patients can be exceptionally frustrating (18),
it is imperative that they not be dismissed.
The illness is not “all in their heads.” Lessons
we have learned from our experiences with
patients with fibromyalgia are applicable to
patients with chronic Lyme disease. We must
address their pain, fatigue, and cognitive
symptoms, as well as the psychological and
behavioral processes that contribute to their
suffering. With further study we may under-
stand the psychological predispositions to
this syndrome.
Lyme Disease, Medically
Unexplained Syndromes, 
and the Anxious Patient
As many as half the patients presenting to
Lyme disease specialty clinics are depressed
and/or suffering from excessive stress (19).
Excessive stress and depression may be due to
having a chronic illness; alternatively, it is
possible that depression and high levels of
stress may have preceded the initial infection
and are symptomatic of an underlying vulner-
ability, which predisposes to chronic, non-
specific symptoms and complaints. In the
only study assessing psychological factors that
predict the course of Lyme disease, a strong
association between a history of prior psycho-
logical trauma and chronic physical symp-
toms was found (20). It is possible that
antecedent traumatic psychological experi-
ences may play an etiologic role in the persis-
tence of symptoms after the infection has
been adequately treated (20). This relation-
ship has been demonstrated in other MUS
conditions, including multiple chemical sen-
sitivity (21), chronic fatigue syndrome, (22),
irritable bowel syndrome (23–26), chronic
pelvic pain (27), and ﬁbromyalgia (28–30).
These ﬁndings and our own clinical obser-
vations have led us to speculate that the symp-
toms of a disproportionate number of chronic
Lyme disease patients may be the product of
chronic psychological stress and resultant neu-
robiological changes. Successful treatment
must address the root causes of these disorders
(biological, psychological, and environmental)
and not merely address the physical and psy-
chological symptoms. Chronic Lyme disease
and other debilitating MUS syndromes are
not mental as opposed to physical health
problems but instead a combination of both.
Working from our biopsychosocial model of
vulnerability, we propose that a multidiscipli-
nary approach combining evidence-based
medical interventions and cognitive-behav-
ioral therapies might best address the symp-
toms and underlying causes of our patients’
suffering and debility.
The Vulnerability Model:
Illness and/or Disease
Our vulnerability model, based on the theory
of stress-diathesis, emphasizes the role of
chronic stressful early experiences and resul-
tant dysfunctional cognitive processes as pre-
disposing factors for MUS syndromes. This is
not to say that all MUS syndrome sufferers
were abused as children. It has been our expe-
rience that many of our patients report other
types of enduring stressful circumstances such
as the death of a parent, social ostracism, or
having parents with unrelenting standards
who drove them to be perfectionistic over-
achievers. Similar to Winfield (31), we pro-
pose that any chronic psychological stress state
in childhood could result in varying levels of
neurobiological dysfunction (stress sensitivity)
and maladaptive belief systems. These belief
systems then, in turn, influence socio–
environmental interactions. Unsuccessful
interactions lead to the conﬁrmation of nega-
tivistic thoughts and self-defeating beliefs in
adulthood. These maladaptive belief systems
predispose one to experiencing excessive levels
of psychological stress because of a negative
bias in information processing (32). For
example, not only are benign events viewed as
threatening, but also there is a perceived
inability to cope effectively with these threat-
ening events. Further, in dealing with symp-
toms of unclear cause or treatment, such
patients may be uniquely vulnerable to a “fear
of the unknown,” an all-encompassing poorly
deﬁned anxiety based on a lack of clear under-
standing of the perceived threat to self.
In addition, we hypothesize that neurobi-
ological changes stemming from chronic early
stress states predisposes one to physiological
manifestations of psychological distress (33).
Once vulnerable, environmental stressors may
then act as triggers for these stress-related syn-
dromes. For example, in post-Lyme disease
syndrome, the trigger might be the infection
with B. burgdorferi, whereas in other psycho-
physiological disorders the trigger could be a
severe emotional stressor such as a loss (death,
divorce, loss of employment) or traumatic
event (spousal abuse, automobile accident,
surgery). In pain (emotional and physical),
literally millions of these patients present to
physicians in search of medical explanations
for their emotional distress and related physi-
ological symptoms. By training, most physi-
cians look for medical explanations, whereas
lack of training and time constraints explain
their hesitancy to explore the psychological
aspects of their patients’ illnesses. Especially
in the case of chronic Lyme disease, “medical-
ization” takes root in what is a very fertile
environment, leading patients to adopt a per-
manent sick role in light of their firmly
entrenched belief that they have an incurable
disease. One cannot approach such patients
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rather, one must use a “biopsychosocial” or
“illness behavior” model of illness if one is to
understand and help these patients.
The acceptance of the sick role by many
of these patients is perhaps the most damag-
ing scar left by chronic Lyme disease. These
are people in search of an explanation. When
they listen to the media, they hear only poor
outcomes and horror stories of denial and
betrayal by physicians and insurance compa-
nies. The media reports “David vs. Goliath”
stories and puts a sensationalist spin on sto-
ries as is needed to attract listeners/readers—
the media are there to entertain and titillate,
not educate. When patients look at the med-
ical literature, often without the assistance of
a physician, what they see is explanations
couched in shades of gray. After therapy,
symptoms of Lyme disease may increase,
decrease, disappear, or persist. Serologic reac-
tivity, by ELISA or Western blot, may
increase, decrease, or remain at a constant
level. Similarly, the immunologic repertoire,
as judged by the number of bands, may
expand, contract, or persist. This lack of cer-
tainty and predictability can yield confusion
and anxiety. It also plays on their fears and
enhances their personal hypervigilance, iden-
tifying and focusing on new physiological
aberrations and experiences (e.g., tachycardia
after exertion, lightheadedness when arising
rapidly, minor forgetfulness in times of detail
overload) and turning them into symptoms of
a disease. These people chronically monitor
their symptoms,  often documenting changes
in detailed diaries that focus on even the most
subtle changes in their apparent health status.
In this way the overanxious “worried well”
can evolve into patients with MUS condi-
tions, in this example, chronic Lyme disease.
People living in Lyme disease–endemic
areas want explanations for their complaints,
their ills. The suburban splendor of their
dreams has been turned into a land of hidden
perils and risks. The risk is the tiny deer tick,
mice, and deer that come out of the wilder-
ness at their backyards. An invisible threat
from the wilderness strikes a primal “fear of
the unknown” into the heart of the urbanized
human, an animal totally dependent on
vision to identify and avoid threats. Thus,
tick-borne infection may evoke a visceral fear
that we in the medical community have not
appreciated or dealt with well. The response
is an outwardly directed hypervigilance, often
leading to extreme actions taken to avoid
Lyme disease, including excessive use of acari-
cides and tick repellants and exaggerated
modifications of their peridomestic proper-
ties, for example, paving over their backyards.
The stressed residents of endemic areas
represent an avid market for a somatic diagno-
sis and a potentially very energetic advocacy
group on behalf of their chosen diagnosis.
We, as academic physicians and researchers,
do not have the access to the media or politi-
cians to compete. But this is the inﬂuence that
has caused state legislators in New Jersey and
Connecticut to determine the minimum
duration of intravenous antibiotics for Lyme
disease that insurance companies must cover
and the criteria to determine when further
antibiotic courses are necessary. Most of these
people are functional, with varying degrees of
(sometimes exaggerated) concerns about a real
public health risk. The lack of a response from
the authorities, coupled with what many in
this group believe is the medical community
not taking these concerns seriously, has often
evoked hostility and anger.
There is another population concerned
with Lyme disease. They are chronically ill
and suffering and have accepted the diagnosis
of chronic Lyme disease as the explanation for
their woes, often despite compelling objective
evidence to the contrary. Some may have once
had the disease but have been treated with
antibiotics in a manner usually deemed “sufﬁ-
cient,” whereas others may have had no prior
illness to suggest Lyme disease. Some of the
latter group may have had the diagnosis of
Lyme disease made solely on the basis of test
results: valid tests with equivocal results, tests
with results misread or misinterpreted, novel
tests whose results cannot be interpreted, or
tests whose results are known to be invalid.
Regardless, technology trumps common sense
and clinical skills, and a diagnosis is made and
accepted. Many of these patients have become
true believers in the phenomenon of chronic
Lyme disease, ﬁercely devoted to the concept
and vociferous members of support and advo-
cacy groups. They may become avid prosely-
tizers and tireless protesters. Often there are
local physicians or advocate “gurus”; fre-
quently, these leaders accuse the medical
establishment of blindness and misdeeds,
claiming that the establishment is interfering
with their ability to properly care for their
many patients by imposing rules and targeting
with investigations. If their chosen physicians,
the first to properly identify their chronic
Lyme disease when so many practitioners
before were unable to do so, are taken away
from them, many patients become more
agitated and energized.
Acceptance of the diagnosis of chronic
Lyme disease provides a number of benefits
for these sufferers. It legitimizes the pain, suf-
fering, and disability. It provides a structure
by which to understand a very frightening
experience. It produces a community with
which to identify and from which to draw
strength and comfort. It gives the sufferer a
means by which to address the suffering on
personal and societal levels. Perhaps most
important, the diagnosis of Lyme disease
denies a psychiatric diagnosis—“this is NOT
in my head, doctor.” Mention of psychoso-
miasis, stress, anxiety, or depression is met
with scornful rejection by the patients. They
often claim their stress is in fact due to the
denial of the diagnosis by insurance compa-
nies and non-“Lyme-literate” physicians.
Believers respond to skepticism about chronic
Lyme disease by spreading this new gospel
with even more fervor. They issue jeremiads
directed at the greedy denying insurance
companies, the blind academic “nonbeliev-
ers,” the nefarious government “cover-up,”
and the confused, doubtful local physician.
Any attempt to deny these people their diag-
nosis or access to their chosen physician or
their chosen modes of therapy is met with
anger, voluble resentment, and active protest.
Psychoneuroimmunologic
Changes in Chronic Lyme
Disease: Exhaustion and Aporia
A paradigm shift might hold the greatest
promise for effective care. Integrative concep-
tualizations of chronic Lyme disease and other
MUS syndromes will guide treatment that
addresses psychophysiological disorders
beyond the symptomatic, palliative level.
Elucidating neurobiological mechanisms such
as hypothalamic–pituitary–adrenal axis dys-
function, pain transmission system dysfunc-
tion, or dysautonomia (34) may dictate
psychophysiological approaches to treatment,
including respiratory sinus arrhythmia
biofeedback (35) and/or trials of novel med-
ications, perhaps those with noradrenergic and
dopaminergic effects. Similarly, psychothera-
peutic interventions will include, but move
beyond, relaxation and coping skills training.
We propose that a more in-depth cognitive
behavioral therapy approach may alter the
underlying maladaptive belief systems that
drive stress-evoking thoughts, self-defeating
behavior, and negative affective processes (32).
All these interventions must be subjected to
empirical evaluation, and once they are vali-
dated, we look forward to testing them in
other MUS syndromes. All interventions must
be offered with great caution because most of
these patients will resist the implied stigma of
a “psychological” diagnosis. We believe the
MUS syndromes represent a prime example of
how psycho-neuro-endocrino-immunology
drives disease and illness.
Unfortunately, any attempt to deny the
diagnosis or to offer an alternative explana-
tion and treatment is dismissed with anger
and animosity. Physicians who present alter-
native explanations are accused of being in
the hip pockets of insurance companies and
are demonized—“how can such a physician
have any motive aside from personal proﬁt?”
Academicians are charged with trying to
diminish the import of Lyme disease—why
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likelihood of obtaining research funding is
not made clear. The venom of the critics sug-
gests that the denial of this diagnosis is strik-
ing close to the heart of a dearly held belief or
value. These patients are experiencing “apo-
ria”, deﬁned in The Random House Dictionary
of the English Language (36) as “the expression
of a simulated or real doubt, as about where to
begin or what to do or say” (in rhetoric) or “a
difﬁculty encountered in establishing the the-
oretical truth of a proposition created by the
presence of evidence both for and against it”
(in logic or philosophy). For our purposes,
aporia is a state of confusion, self-doubt, and
exhaustion! This manifests in patients as an
inability to adequately formulate and articu-
late their complaints, their fears of unknown
threats/disease, and their elusive sense of
anguish. They are “stuck” and thoroughly
unable to deal effectively with their health care
needs. Defensive anger stems from the threat
of removing their diagnosis; illness behavior in
their experience of chronic Lyme disease has
become their only fundamentally acceptable
“language” for expression of their distress; to
borrow a term from the psychology literature,
it is their “ego-syntonic” language.
In the ﬁnal analysis there is a struggle over
who defines a new and emerging disease:
patients, their chosen clinicians and advocacy
groups, or the biomedical establishment’s
physicians and scientists. It is clear that the
scientiﬁc community faces a formidable chal-
lenge. Unexplained suffering and fear of the
unknown are far greater than fear of even the
worst, incurable disease and drive these
patients to extreme measures. Dealing with
the phenomenon of chronic Lyme disease, a
new constituent of the MUS syndromes com-
plex, requires an appreciation of its complex
psychopathogenesis. We need to appreciate
and study the aporology of MUS conditions—
to describe and heal the sense of being lost,
hopeless, and vulnerable.
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